ARCHIVES

FDA Approves Xeloda For Colon Cancer; Phase III Data Not Reviewed By ODAC.

This article is from The Cancer Letter archive.

Vol. 27 No. 18 | May 4, 2001

Download PDF Visit The Full Archive

Related Articles

In Brief: Gerald Dodd, Walter Lawrence Head ACS; Reauthorization Bills Expected Early ‘91

November 16, 1990

Two OAM Advisors Criticize Third over ACS Membership

July 23, 1993

Mace Rothenberg Leaves Vanderbilt For Pfizer Oncology.

November 14, 2008

The White House: President’s Proclamation For Breast Cancer Awareness Month

October 9, 1998

Mendelsohn Defends ImClone’s Actions And His Role In Development of C225

October 18, 2002

HEW Money Bills Mark Up Set May 26

May 20, 1977